CytoMed Therapeutics Limited Royalty Expense
CytoMed Therapeutics Limited (GDTC) reported Royalty Expense of SGD 15.51 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:RoyaltyExpense · last filed 2026-03-31
| Period end | Royalty Expense 12 month |
|---|---|
| 2025-12-31 | 15.51K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 11.37K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 30.38K SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | 9.59K SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | 10.70K SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | 10.70K SGD 20-F · filed 2023-05-01 |